Clearance Summary
Quicktome Software Suite received FDA 510(k) clearance under submission number K222359, sponsored by Omniscient Neurotechnology Pty Ltd (O8t). The device was reviewed via the Traditional premarket notification pathway and assigned to the Radiology review panel. The statutory decision date of record is 2023-05-30.
- Submission: K222359
- Applicant / Sponsor: Omniscient Neurotechnology Pty Ltd (O8t)
- Clearance pathway: Traditional
- Review panel: Radiology
- Device class: Class II
- Regulation citation: 21 CFR 892.2050
- Decision date: 2023-05-30
Classification & Regulation
This clearance is catalogued under FDA product code LLZ and 21 CFR 892.2050, within the Radiology review panel as a Class II device.